Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome.
Anja E Sørensen, Pernille B Udesen, Grzegorz Maciag, Julian Geiger, Negar Saliani, Andrzej S Januszewski, Guozhi Jiang, Ronald C Ma, Anandwardhan A Hardikar, Marie Louise M Wissing, Anne Lis M Englund, Louise T Dalgaard
Frontiers in Medicine | Published : 2019
Polycystic ovary syndrome (PCOS) remains one of the most common endocrine disorder in premenopausal women with an unfavorable metabolic risk profile. Here, we investigate whether biochemical hyperandrogenism, represented by elevated serum free testosterone, resulted in an aberrant circulating microRNA (miRNAs) expression profile and whether miRNAs can identify those PCOS women with metabolic syndrome (MetS). Accordingly, we measured serum levels of miRNAs as well as biochemical markers related to MetS in a case-control study of 42 PCOS patients and 20 Controls. Patients were diagnosed based on the Rotterdam consensus criteria and stratified based on serum free testosterone levels (≥0.034 nmo..View full abstract